Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Nightingale

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
Plos One|April 18, 2015
A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in NepalAjit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Plos One|August 14, 2015
Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in NepalAjit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
Nature Reviews. Neurology|January 16, 2024
Reply to 'Cognitive criteria in HIV: greater consensus is needed'Sam Nightingale, Paola Cinque, Ameet Dravid, et al.
Nature Reviews. Neurology|June 13, 2023
Cognitive impairment in people living with HIV: consensus recommendations for a new approachSam Nightingale, Beau Ances, Paola Cinque, et al.
Ebiomedicine|September 26, 2025
Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global frameworkCyprian M Mostert, Chinedu Udeh-Momoh, Andrea Sylvia Winkler, et al.
Wellcome Open Research|July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 2, 2024
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impactRaj Kalaria, Gladys Maestre, Simin Mahinrad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2023
The Nairobi Declaration-Reducing the burden of dementia in low- and middle-income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICsGladys Maestre, Maria Carrillo, Raj Kalaria, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
Plos One|April 18, 2015
A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in NepalAjit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Plos One|August 14, 2015
Correction: A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in NepalAjit Rayamajhi, Sam Nightingale, Nisha Keshary Bhatta, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
Nature Reviews. Neurology|January 16, 2024
Reply to 'Cognitive criteria in HIV: greater consensus is needed'Sam Nightingale, Paola Cinque, Ameet Dravid, et al.
Nature Reviews. Neurology|June 13, 2023
Cognitive impairment in people living with HIV: consensus recommendations for a new approachSam Nightingale, Beau Ances, Paola Cinque, et al.
Ebiomedicine|September 26, 2025
Broadening dementia risk models: building on the 2024 Lancet Commission report for a more inclusive global frameworkCyprian M Mostert, Chinedu Udeh-Momoh, Andrea Sylvia Winkler, et al.
Wellcome Open Research|July 21, 2021
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM]Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 2, 2024
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impactRaj Kalaria, Gladys Maestre, Simin Mahinrad, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 11, 2023
The Nairobi Declaration-Reducing the burden of dementia in low- and middle-income countries (LMICs): Declaration of the 2022 Symposium on Dementia and Brain Aging in LMICsGladys Maestre, Maria Carrillo, Raj Kalaria, et al.
Pageof 5